Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 4Phase 1 4Phase NA 3

Status

Completed 3Terminated 2

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 1Head & Neck 1Genitourinary 1

Conditions

Parathyroid Neoplasms 1Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1Leukemia, B-Cell 1Hyperparathyroidism, Primary 1Diabetes Mellitus 1Carcinoma, Renal Cell 1

Interventions

Cisplatin 186Carboplatin 181Paclitaxel 175Docetaxel 144Cyclophosphamide 129Dexamethasone 117pembrolizumab 106Doxorubicin 103Bevacizumab 103Gemcitabine 102Rituximab 96Prednisone 87Fluorouracil 86Pemetrexed 81Radiotherapy 77Vincristine 71Etoposide 71Capecitabine 69Nivolumab 68Trastuzumab 67Leucovorin 64Cytarabine 57Methotrexate 52Oxaliplatin 49atezolizumab 47Lenalidomide 43Ipilimumab 40Filgrastim 40Bortezomib 39Sorafenib 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Has results × Tablets × Clear all
NCT04233034 2024-11-27

CLVer

Jaeb Center for Health Research

Phase 3 Completed
113 enrolled 42 charts
Other hematologic neoplasm

Diabetes Mellitus, Leukemia, Hairy Cell

NCT03027557 2021-05-25

DENOCINA

Aalborg University Hospital

Phase 3 Completed
46 enrolled 49 charts
Head & Neck

Parathyroid Neoplasms, Hyperparathyroidism, Primary

NCT01865747 2021-04-27

METEOR

Exelixis

Phase 3 Completed
658 enrolled 15 charts
Genitourinary

Carcinoma, Renal Cell

NCT01827930 2020-12-31

MIM

Institut Bergonié

Phase 3 Terminated
68 enrolled 13 charts
Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

NCT00748189 2019-06-25

COMPLEMENT 1

Novartis

Phase 3 Terminated
447 enrolled 32 charts
LymphoidOther hematologic neoplasm

Neoplasms, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡